China approved the use of military experimental vaccines against coronavirus infection, developed by the Chinese company for the production of Biologics and vaccines CanSino research Institute of the Academy of military Sciences. This became known from the statement of the company CanSino Biologics, said BAGNET.
“The use of Ad5-nCoV are now limited to only military structures, and cannot have a broader scope without the approval of the Department of logistics of the people’s liberation army of China”, – said in a statement.
According to the company, the Central military Commission of China has approved the use of the vaccine for a period of one year.
As shown by clinical studies that the potential vaccine Ad5-nCoV safe and “somewhat” effective.
The developer also said that the drug prevents the development of complications caused by the coronavirus.
While Biologics CanSino notes that the commercial success of the vaccine cannot be guaranteed.
Only in China are eight potential vaccines. Ad5-nCoV is one of them.
Previously, the Company China National Biotec Group (CNBG), which is developing two vaccines against coronavirus, announced the successful results of testing on humans one of them.